Long‐Term Outcomes of Inferior Meatus Augmentation Procedure to Treat Empty Nose Syndrome
- 15 May 2021
- journal article
- research article
- Published by Wiley in The Laryngoscope
- Vol. 131 (11) , E2736-E2741
Abstract
Objectives/Hypothesis: We sought to report the long‐term, symptom‐focused, prospective outcomes in empty nose syndrome (ENS) patients after undergoing inferior meatus augmentation procedure (IMAP) through use of four validated questionnaires: Empty Nose Syndrome 6‐Item Questionnaire (ENS6Q), 22‐item Sino‐Nasal Outcome Test (SNOT‐22), Generalized Anxiety Disorder 7‐Item Scale (GAD‐7), and Patient Health Questionnaire‐9 (PHQ‐9).Study Design: Prospective case series.Methods: A single‐center prospective case series was performed for patients diagnosed with ENS who underwent IMAP between July 2017 and February 2020. Diagnosis of ENS was based on the following criteria: 1) reported discomfort with nasal breathing and/or paradoxical nasal obstruction after inferior turbinate reduction, 2) a positive ENS6Q score of at least 11, and 3) a positive cotton test. Questionnaire responses were recorded prior to surgery as well as 1, 3, 6, and 12 months postoperatively.Results: Seventeen eligible patients were included. Mean ENS6Q scores were significantly reduced at all postoperative time points (p < .0001, p < .0001, p < .0001, p = .0003). Of the six ENS6Q subdomains, five (suffocation, dryness, sense of diminished airflow, nasal crusting, and nasal burning) were significantly reduced 1‐year postoperatively (p < .0001, p = .0004, p = .0136, p = .0114, p = .0080, respectively). SNOT‐22 scores were significantly reduced at all time points (p = .0021, p = .0227, p = .0004, and p = .0025). Of the SNOT‐22 subdomains, the sleep subdomain was significantly reduced 1‐year postoperatively (p = .0432). Low baseline GAD‐7 and PHQ‐9 scores were recorded at 7 and 9.4, respectively, and although scores at all postoperative time points were reduced, there was no statistical significance.Conclusion: IMAP via implant of cadaveric rib cartilage provides significant, long‐term improvements in ENS‐specific and general sinonasal symptoms.Level of Evidence: 4 Laryngoscope, 131:E2736–E2741, 2021Keywords
This publication has 19 references indexed in Scilit:
- Inferior Meatus Augmentation Procedure (IMAP) to Treat Empty Nose Syndrome: A Pilot StudyOtolaryngology–Head and Neck Surgery, 2020
- Use of intranasal submucosal fillers as a transient implant to alter upper airway aerodynamics: implications for the assessment of empty nose syndromeInternational Forum of Allergy & Rhinology, 2019
- Defining surgical criteria for empty nose syndrome: Validation of the office‐based cotton test and clinical interpretability of the validated Empty Nose Syndrome 6‐Item QuestionnaireThe Laryngoscope, 2017
- The Empty Nose Syndrome 6‐Item Questionnaire (ENS6Q): a validated 6‐item questionnaire as a diagnostic aid for empty nose syndrome patientsInternational Forum of Allergy & Rhinology, 2016
- Inferior turbinate reconstruction using porcine small intestine submucosal xenograft demonstrates improved quality of life outcomes in patients with empty nose syndromeInternational Forum of Allergy & Rhinology, 2015
- Costal Cartilage Is a Superior Implant Material than Conchal Cartilage in the Treatment of Empty Nose SyndromeOtolaryngology–Head and Neck Surgery, 2013
- β‐Tricalcium Phosphate Implant to Repair Empty Nose SyndromeOtolaryngology–Head and Neck Surgery, 2013
- Study of inferior turbinate reconstruction with Medpor for the treatment of empty nose syndromeThe Laryngoscope, 2012
- Acellular dermal (alloderm) grafts versus silastic sheets implants for management of empty nose syndromeEuropean Archives of Oto-Rhino-Laryngology, 2012
- Hyaluronic Acid Gel in the Treatment of Empty Nose SyndromeAmerican Journal of Rhinology & Allergy, 2011